Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-014529
Filing Date
2018-05-29
Accepted
2018-05-29 17:11:24
Documents
62
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q surf-10q_20180331.htm 10-Q 1917970
2 EX-31.1 surf-ex311_11.htm EX-31.1 17933
3 EX-32.1 surf-ex321_9.htm EX-32.1 7861
  Complete submission text file 0001564590-18-014529.txt   6609660

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT surf-20180331.xml EX-101.INS 1460056
5 XBRL TAXONOMY EXTENSION SCHEMA surf-20180331.xsd EX-101.SCH 39661
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE surf-20180331_cal.xml EX-101.CAL 39462
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE surf-20180331_def.xml EX-101.DEF 146296
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE surf-20180331_lab.xml EX-101.LAB 321678
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE surf-20180331_pre.xml EX-101.PRE 281463
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38459 | Film No.: 18865483
SIC: 2836 Biological Products, (No Diagnostic Substances)